Announcements Trials
Browse Landscape

Status

No longer available 3

Sponsor Class

OTHER 3

Study Type

Interventional 76Observational 20Expanded_access 3

Sponsor

Cancer Type

Endocrine 3NET 1Head & Neck 1CNS 1

Conditions

Pheochromocytoma 7Neuroendocrine Tumors 7Paraganglioma 5Neuroblastoma 5Insulinoma 3Carcinoid Tumor 3Recurrence 2Neoplasms 2Hypoglycemia 2Hyperinsulinism 2Carcinoma, Medullary 2Adenoma, Islet Cell 2Thyroid cancer, medullary 1Thyroid Cancer, Papillary 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Liposarcoma 1Fibrosarcoma 1Congenital Hyperinsulinism 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Beckwith-Wiedemann Syndrome 1

Interventions

gallium Ga 68 dotatate 1fluorodopa F 18 1Gallium-68 1Ga(III)-DOTATOC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Expanded_access × Carcinoid Tumor × Endocrine × Clear all
NCT02431715 2023-02-21

18F-FDOPA PET in Neuroendocrine Tumours

British Columbia Cancer Agency

No longer available
CNSEndocrineHead & Neck

Thyroid cancer, medullary, Carcinoid Tumor, Insulinoma, Neuroblastoma, Paraganglioma, Pheochromocytoma

NCT01980732 2017-08-23

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Stanford University

No longer available
Endocrine

Carcinoid Tumor, Adenoma, Islet Cell

NCT02375464 2016-11-08

Gallium-68 DOTATOC for Management of Neuroendocrine Tumors

Northwell Health

No longer available
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡